tidytlg
A tables-listings-graphs package that reached CRAN and then went quiet.
Comparison · Analytics
DoseFinding vs rlistings
A side-by-side editorial comparison of DoseFinding and rlistings — release velocity, themes, recent moves, and the top alternatives to consider.
Shared themes:clinical-trials
DoseFinding vs rlistings: at a glance
What is DoseFinding?
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
What is rlistings?
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
rlistings renders clinical-trial subject listings and paginates them for regulatory output, sitting alongside rtables on the shared formatters engine. The releases in this window are dominated by pagination correctness: repeated key columns across pages, splitting by a variable, ordered-factor handling, column gaps, and font metrics. Development is a large rotating contributor set inside the insightsengineering organisation.
DoseFinding vs rlistings: editorial side-by-side
DoseFinding
0.0ANALYTICS
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
◆ Current state
DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.
◆ Where it's heading
The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.
◆ Prediction
Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.
rlistings
0.0ANALYTICS
Clinical listings that keep inheriting their hardest problem — pagination — from the layer below.
◆ Current state
rlistings renders clinical-trial subject listings and paginates them for regulatory output, sitting alongside rtables on the shared formatters engine. The releases in this window are dominated by pagination correctness: repeated key columns across pages, splitting by a variable, ordered-factor handling, column gaps, and font metrics. Development is a large rotating contributor set inside the insightsengineering organisation.
◆ Where it's heading
The package is progressively delegating pagination to formatters rather than implementing it — paginate_listing() was refactored to call formatters' paginate_to_mpfs() directly, and truetype font support arrived through a new formatters API. That reduces duplicated logic but ties the package's page-break behaviour to a dependency it shares with rtables. Feature work beyond pagination is thin: better error messages for unsupported column classes, a cheatsheet.
◆ Prediction
Expect pagination fidelity to remain the focus, with changes arriving as formatters exposes more of its layout machinery rather than as rlistings-native features.
Alternatives to DoseFinding and rlistings
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or rlistings.
Tplyr
Tplyr made clinical summary tables explain where every number came from.
hoardr
A cache-directory helper that has shipped nothing but CRAN-triggered patches for seven years.
gigs
gigs redesigned its whole conversion API for rOpenSci, then spent three releases getting the docs to build.
riem
A weather-data client that keeps rewriting its HTTP layer while slowly tightening its API.
datasetjson
datasetjson rebuilt its object model to track the CDISC Dataset-JSON 1.1 schema.
See all DoseFinding alternatives → · See all rlistings alternatives →
Recent activity from DoseFinding and rlistings
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 1y agoDoseFindingConditional and predictive power for interim analyses
- 1y agoDoseFindingModel averaging arrives for dose-response fitting ⚡
- 1y agorlistingsError and message handling for difftime and zero-row listings
- 1y agorlistingsTrueType font support and col_gap in pagination
- 1y agoDoseFindingPackage moves to openpharma under new maintainership
- 2y agorlistingssplit_into_pages_by_var() and pagination moved onto formatters
- 2y agoDoseFindingCompliance update for R-devel
- 3y agoDoseFindingpowMCTBinCount bug fix
Frequently asked questions
What is the difference between DoseFinding and rlistings?
Both compete on the same themes — clinical-trials — within Analytics. DoseFinding and rlistings are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DoseFinding better than rlistings?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and rlistings are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DoseFinding?
Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.
What are the best alternatives to rlistings?
Top rlistings alternatives in Analytics are ranked by recent ship velocity. Browse the "rlistings alternatives" section above for the current picks, or visit /alternatives/rlistings for the full list with editorial commentary on each.